What Are the Side Effects of Maternal IVIG for FNAIT?
At a Glance
Maternal IVIG infusions for FNAIT commonly cause flu-like side effects such as headaches, fatigue, and muscle aches. You can effectively manage these symptoms by staying aggressively hydrated, requesting a slower infusion rate, and taking doctor-approved premedications.
In this answer
4 sections
Intravenous immunoglobulin (IVIG) is the gold-standard treatment to prevent complications in pregnancies affected by Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) [1][2]. While this treatment is highly effective at protecting your baby, receiving weekly high-dose infusions is an intense physical commitment. Side effects are common and can range from mild fatigue to severe headaches, but serious long-term complications for the mother are very rare [3]. With proactive management, a solid support system, and the right medical strategies, you can safely navigate this treatment.
The Reality of Infusion Day
Weekly infusions starting early in the second trimester mean you will receive 20 or more intravenous (IV) treatments before you deliver. Because a slower drip prevents side effects, a single session can last anywhere from 4 to 8 hours [4]. This requires significant logistical planning. Furthermore, repeated IVs can be hard on your veins. Staying warm and highly hydrated makes your veins easier to access, and some patients eventually discuss semi-permanent options, like a PICC line or port, with their doctor.
Because IVIG is a concentrated blood product made from the antibodies of thousands of donors, your body has to work hard to process it. It is very common to experience “flu-like” symptoms during or in the days following an infusion. The most frequently reported mild to moderate side effects include:
- Headaches: Ranging from a dull ache to intense throbbing [5].
- Extreme Fatigue: Feeling completely drained on the day of and the day after the infusion [5].
- Muscle and Joint Aches (Myalgia): General body soreness [5].
- Nausea and Flushing: Feeling warm, flushed, or mildly sick to your stomach [5].
Practical Survival & Mitigation Strategies
Living with weekly IVIG infusions requires a proactive approach. Doctors and specialized infusion nurses strongly recommend several strategies to minimize these side effects:
- Aggressive Hydration: Staying exceptionally well-hydrated is one of the most effective ways to prevent headaches and protect your kidneys [6]. Unless your doctor advises otherwise, a common goal is to drink 64 to 80 ounces of water starting the day before your infusion, the day of, and the day after. Always confirm your specific fluid target with your physician.
- Slowing the Infusion Rate: The speed at which IVIG enters your bloodstream directly impacts how you feel. Using a “slow start” or rate escalation protocol—where the nurse starts the drip very slowly and only increases it if you are feeling well—can significantly reduce headaches and nausea [7][4].
- Premedication and Planning: To head off flu-like symptoms, doctors frequently recommend taking approved medications, such as acetaminophen (Tylenol) and an antihistamine (like Benadryl), shortly before the infusion [4]. Important warning: Antihistamines cause severe drowsiness. When combined with the extreme fatigue of IVIG, it is often unsafe to drive yourself home or care for a toddler alone. Plan to have a driver and arrange childcare on infusion days.
- Changing the Product Lot: IVIG is biologically derived, and different brands use different stabilizers (like sucrose or amino acids) and contain varying levels of specific antibodies (like IgA). If you consistently have strong adverse reactions, your doctor can try switching to a different brand or medication lot to see if your body tolerates it better [8].
Rare but Serious Risks: When to Get Immediate Help
While minor flu-like symptoms are expected, you and your support team should be aware of rare but serious complications that require immediate medical attention:
- Aseptic Meningitis: This is a rare, non-infectious inflammation of the brain’s lining caused by the immune system’s reaction to IVIG [9][10]. Symptoms include an extraordinarily severe headache, stiffness in the neck, and a high sensitivity to light. If this occurs, contact your doctor immediately. It typically resolves rapidly once the infusion is stopped, and most patients can safely resume therapy later [5].
- Thrombosis (Blood Clots): Pregnancy naturally increases your risk of blood clots, and high-dose IVIG can elevate this risk further [11][6]. Go to the emergency room immediately if you experience red-flag symptoms like sudden shortness of breath, chest pain, or swelling, warmth, and redness in one leg.
- Severe Allergic Reactions (Anaphylaxis): Though rare, severe allergic reactions can occur during the infusion, particularly in patients who have a known IgA deficiency [12]. Report any sudden difficulty breathing, throat tightness, or severe hives to your infusion nurse instantly.
Routine Safety Monitoring
While you manage the day-to-day logistics, your care team will monitor you for rare internal side effects. IVIG can occasionally cause hemolysis (the destruction of red blood cells, leading to anemia) or pancytopenia (a drop in all types of blood cells) [13][5]. Please do not let this alarm you—it is standard medical practice for your doctor to order periodic complete blood counts (CBC) to watch for these rare changes and ensure you remain healthy throughout your pregnancy [13].
Common questions in this guide
How can I prevent headaches after my IVIG infusion?
Are flu-like symptoms normal after receiving IVIG during pregnancy?
What are the signs of a severe IVIG reaction that require immediate medical help?
Can I drive myself home after my IVIG infusion?
Why does my doctor check my blood counts during weekly IVIG therapy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What specific hydration goal (in ounces) should I aim for before and after my infusions, and are there any fluid restrictions I should know about?
- 2.Since pregnancy naturally increases the risk of blood clots, how will we monitor for the added thrombosis risk from the weekly IVIG?
- 3.If I have a known IgA deficiency, what precautions will be taken to prevent a severe allergic reaction?
- 4.Would I be a candidate for a semi-permanent line, like a PICC or a port, to save my veins from weekly sticks?
- 5.What premedication protocol do you recommend, and how sedating will those medications be?
- 6.If I develop a severe headache or suspect aseptic meningitis, what is our immediate emergency contact plan?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (13)
- 1
Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia.
Lakkaraja M, Jin JC, Manotas KC, et al.
Transfusion 2016; (56(10)):2449-2454 doi:10.1111/trf.13779.
PMID: 27611703 - 2
Perinatal Outcome and Long-Term Neurodevelopment after Intracranial Haemorrhage due to Fetal and Neonatal Alloimmune Thrombocytopenia.
Winkelhorst D, Kamphuis MM, Steggerda SJ, et al.
Fetal diagnosis and therapy 2019; (45(3)):184-191 doi:10.1159/000488280.
PMID: 29730660 - 3
Update on the Use of Intravenous Immunoglobulin in Pregnancy.
D'Mello RJ, Hsu CD, Chaiworapongsa P, Chaiworapongsa T
NeoReviews 2021; (22(1)):e7-e24 doi:10.1542/neo.22-1-e7.
PMID: 33386311 - 4
Adverse Reactions Associated with Intravenous Immunoglobulin Administration in the Treatment of Neurological Disorders: A Systematic Review.
Jiang M, Kimber JS, Gupta A, et al.
International archives of allergy and immunology 2023; (184(6)):513-528 doi:10.1159/000529110.
PMID: 37015212 - 5
Acute Aseptic Meningitis Temporally Associated with Intravenous Polyclonal Immunoglobulin Therapy: A Systematic Review.
De Felice ELT, Toti GF, Gatti B, et al.
Clinical reviews in allergy & immunology 2024; (66(2)):241-249 doi:10.1007/s12016-024-08989-1.
PMID: 38739354 - 6
Complications of Immunoglobulin Therapy and Implications for Treatment of Inflammatory Neuropathy: A Review.
Abbas A, Rajabally YA
Current drug safety 2019; (14(1)):3-13 doi:10.2174/1574886313666181017121139.
PMID: 30332974 - 7
Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency.
Geng B, Clark K, Evangelista M, Wolford E
Frontiers in immunology 2022; (13()):1075527 doi:10.3389/fimmu.2022.1075527.
PMID: 36818468 - 8
Intravenous immunoglobulin induced pancytopenia while preventing development of gestational alloimmune liver disease: A case report.
Sarker M, DeBolt C, Strong N
Case reports in women's health 2022; (35()):e00422 doi:10.1016/j.crwh.2022.e00422.
PMID: 35646608 - 9
Intravenous Immunoglobulin-Induced Aseptic Meningitis-A Narrative Review of the Diagnostic Process, Pathogenesis, Preventative Measures and Treatment.
Kretowska-Grunwald A, Krawczuk-Rybak M, Sawicka-Zukowska M
Journal of clinical medicine 2022; (11(13)) doi:10.3390/jcm11133571.
PMID: 35806861 - 10
Intravenous Immunoglobulin-Induced Aseptic Meningitis in a Dermatomyositis Patient.
Rosoph L, Ladel L, Patel R, Webster P
Cureus 2024; (16(4)):e58242 doi:10.7759/cureus.58242.
PMID: 38745808 - 11
Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs.
Ammann EM, Haskins CB, Fillman KM, et al.
American journal of hematology 2016; (91(6)):594-605 doi:10.1002/ajh.24358.
PMID: 26973084 - 12
Intravenous immunoglobulin and the current risk of moderate and severe anaphylactic events, a cohort study.
Martinez C, Wallenhorst C, van Nunen S
Clinical and experimental immunology 2021; (206(3)):384-394 doi:10.1111/cei.13665.
PMID: 34562316 - 13
IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia.
Herrmann A, Samelson-Jones BJ, Brake S, Samelson R
AJP reports 2017; (7(3)):e197-e200 doi:10.1055/s-0037-1607055.
PMID: 28970962
This page provides educational information about the side effects of maternal IVIG infusions for FNAIT. It does not replace professional medical advice, diagnosis, or emergency protocols established by your maternal-fetal medicine specialist.
Get notified when new evidence is published on Fetal and neonatal alloimmune thrombocytopenia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.